Le Lézard
Classified in: Business
Subject: STR

IIROC Trading Resumption - SDI


VANCOUVER, BC, Aug. 4, 2022 /CNW/ - Trading resumes in: 

Company: Stampede Drilling Inc.

TSX-Venture Symbol: SDI 

All Issues: Yes

Resumption (ET): 9:30 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions


These press releases may also interest you

at 07:45
Ivy Tech Community College, Indiana's largest postsecondary institution and the nation's largest singly accredited community college, has selected eCampus.com, a leader in online bookstores and collegiate retail solutions, to...

at 07:45
AtkinsRéalis [SNC-Lavalin Group Inc.] , a fully integrated professional services project management company with offices around the world, is thrilled to announce that it has been awarded a contract from the Groupe Héritage Île-d'Orléans S.E.N.C. as...

at 07:39
ADENTRA Inc. ("ADENTRA" or the "Company") today announced that it will report its first quarter 2024 results on Wednesday, May 8, 2024 after the markets close. The Company will also host a conference call on Thursday, May 9, 2024 at 8:00 am Pacific...

at 07:35
VSE Corporation ("VSE" or the "Company") , a leading provider of aftermarket distribution and repair services, announced today that it will issue first quarter 2024 results after the market close on Wednesday, May 8, 2024. A conference call will be...

at 07:35
City Holding Company ("Company" or "City") , a $6.3 billion bank holding company headquartered in Charleston, West Virginia, today announced net income of $29.5 million and diluted earnings of $1.97 per share for the quarter ended March 31, 2024. For...

at 07:35
Agenus Inc. ("Agenus") , a leader in developing novel immunological agents to treat various cancers, today announced the Company will release its first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024. Agenus executives...



News published on and distributed by: